Neumann Advisory Hong Kong LTD Moderna, Inc. Transaction History
Neumann Advisory Hong Kong LTD
- $341 Million
- Q4 2024
A detailed history of Neumann Advisory Hong Kong LTD transactions in Moderna, Inc. stock. As of the latest transaction made, Neumann Advisory Hong Kong LTD holds 21,285 shares of MRNA stock, worth $839,054. This represents 0.26% of its overall portfolio holdings.
Number of Shares
21,285
Previous 21,285
-0.0%
Holding current value
$839,054
Previous $1.42 Million
37.81%
% of portfolio
0.26%
Previous 0.58%
Shares
6 transactions
Others Institutions Holding MRNA
# of Institutions
913Shares Held
236MCall Options Held
10.6MPut Options Held
18.7M-
Vanguard Group Inc Valley Forge, PA40.2MShares$1.59 Billion0.05% of portfolio
-
Baillie Gifford & CO38.9MShares$1.53 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.01 Billion0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$664 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$285 Million28.47% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $15.4B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...